DAVID MASON: Open Payments
NPI 1790261550 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$436 in 17 payments from 9 companies in 2025. Trend: 2023 $245 · 2024 $204 · 2025 $436
Food & beverage: $436
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $111 |
| Fresenius USA Marketing, Inc. | 5 | $108 |
| Travere Therapeutics, Inc. | 2 | $52 |
| Otsuka America Pharmaceutical, Inc. | 2 | $41 |
| GlaxoSmithKline, LLC. | 2 | $35 |
| Amgen Inc. | 1 | $30 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $26 |
| Apellis Pharmaceuticals, Inc. | 1 | $17 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $14 |
Products named: Ozempic, VELPHORO, JYNARQUE, BEXSERO, KRYSTEXXA, JARDIANCE, Empaveli, Kerendia.
Industry payments across FL — which companies pay providers there.
